Smartleaf Asset Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.88M Hold
23,270
0.06% 271
2026
Q1
$2M Buy
23,270
+1,909
+9% +$183K 0.07% 246
2025
Q4
$2.06M Buy
21,361
+2,086
+11% +$203K 0.08% 227
2025
Q3
$1.81M Buy
19,275
+5,105
+36% +$469K 0.11% 203
2025
Q2
$1.22M Sell
14,170
-2,280
-14% -$193K 0.11% 213
2025
Q1
$1.44M Buy
16,450
+1,429
+10% +$128K 0.14% 165
2024
Q4
$1.2M Buy
15,021
+1,336
+10% +$116K 0.12% 180
2024
Q3
$1.22M Buy
13,685
+2,468
+22% +$208K 0.15% 157
2024
Q2
$890K Buy
11,217
+1,836
+20% +$151K 0.15% 162
2024
Q1
$815K Buy
9,381
+5,112
+120% +$436K 0.16% 156
2023
Q4
$350K Buy
+4,269
New +$325K 0.09% 214

Other funds holding MDT

Smartleaf Asset Management's MDT Position: Q2 2026 in Review

Smartleaf Asset Management held its Medtronic (MDT) position steady in Q2 2026 at 23,270 shares worth $1.88M. The position accounts for 0.06% of the portfolio, ranked #271.

Smartleaf Asset Management first reported a position in MDT in Q4 2023 and has held it in 11 quarters since. The position peaked at $2.06M in Q4 2025. 2,141 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Smartleaf Asset Management held 23,270 shares of Medtronic worth $1.88M as of Q2 2026.
  • Smartleaf Asset Management left its Medtronic share count unchanged in Q2 2026.
  • Medtronic made up 0.06% of Smartleaf Asset Management's portfolio in Q2 2026, its #271 holding.
  • Smartleaf Asset Management first reported a position in Medtronic in Q4 2023 and has held it in 11 quarters since.
  • Smartleaf Asset Management's Medtronic position peaked at $2.06M in Q4 2025.
  • 2,141 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Smartleaf Asset Management's 13F filing for Q2 2026, filed 12 Aug 2026.